mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.07 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.07 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.07 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.08 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.08 |